group, suggesting that home circumstances were not influencing admission to any great extent.
Breast-feeding certainly does not give complete protection. Work done by Toms et a16 has shown that breast milk varies in its antirespiratory syncytial virus activity; only four of 16 mothers tested had high levels of IgA specific for respiratory syncytial virus and five of 17 had lymphocytes sensitised to respiratory syncytial virus in their milk. This probably relates to recent exposure of the mother to the virus.
It is interesting that infants do not need to be breast-fed at the time of exposure to infection to be protected; there appears to be a lasting effect. This may be due to the fact that lymphocytes in the colostrum or milk that are sensitised to respiratory syncytial virus colonise the infant's nasopharynx, or to stimulation of the infant's own immune response by transfer of sensitised T cells or of antigen on macrophages. Recent work has suggested that the IgE response in the respiratory tract may be important in the pathogenesis of bronchiolitis,7 and breast milk in rats has been shown to suppress the IgE response. 8 This demonstration that breast-feeding probably influences respiratory syncytial virus infection in infants suggests three possible approaches to the problem. Firstly, it gives another reason for encouraging mothers to breast-feed their babies. Secondly, it has prompted us to look further at the immune status of mothers and how this is reflected in their milk and in their infants: boosting mothers' immunity might increase the protection they give to their babies. Thirdly, it Neiirop.s\chiatric finidinigs- Table III shows individual symptoms and signs, and table IV the overall findings. About two-thirds of both groups had some neuropsychiatric abnormality. The most common finding in the patients with vitamin B12 deficiency was peripheral neuropathy (in 400,), the main features of which were paraesthesia, Relationz of neuropsy,chiatric to haematological findiigs-There were no significant differences in the vitamin and haemoglobin concentrations or mean cell volume between those with and without neuropsychiatric abnormalities in either deficiency state. There were no correlations between the haematological or biochemical variables and any particular neuropsychiatric disorder. Among patients with neuropsychiatric disorders haemoglobin concentration was above 12 g/dl in 44%, with vitamin B12 deficiency and 45% with folate deficiency; and the mean cell volume was below 96 mm3 in 280' with vitamin B12 deficiency and 41°o with folate deficiency.
Discussion
The patients in this study were deficient in either vitamin B12 or folic acid to a degree sufficient to produce megaloblastic changes in the bone marrow. Interesting similarities and differences arose in the associated neuropsychiatric findings. About one-third of each group had no clinical disturbance referable to the nervous system, and one-quarter had evidence of organic mental change. The most common abnormality in vitamin B,2 deficiency, however, was peripheral neuropathy (in 40%), indicated by paraesthesia, absent reflexes, and impaired vibration sense mainly in the legs. Electrophysiological evidence of subclinical neuropathy was found in a further 25 O, so that, overall, clinical or electrical neuropathy was three times more common in vitamin B12 than folate deficiency. Subacute combined degeneration of the cord was present in only 16%/ of the patients with vitamin B12 deficiency and was always accompanied by clinical or electrical evidence of neuropathy. This is also true of patients presenting primarily to neurologists with subacute combined degeneration of the cord (D Jefferson, personal communication). The condition was not seen with folate deficiency in this series but has only rarely been reported. 8 By contrast, the most common neuropsychiatric abnormality in folate deficiency was an affective disturbance, which occurred in 56% of the patients and was thus almost three times more common than in vitamin B12 deficiency. Depression has been a prominent feature of the neuropsychiatric disorders attributed to folic acid deficiency.6
It cannot be assumed that all the neurological abnormalities in these patients were the result of the deficiencies. Both series inevitably included patients with gastrointestinal disease or dietary problems in whom other deficiencies might reasonably be expected. Even in pernicious anaemia secondary deficiencies may occur owing to megaloblastic change in the gastrointestinal tract, and associated autoimmune diseases might also sometimes play a part; certainly the presence or type of neuropsychiatric abnormality is not obviously related to the vitamin concentrations, or, as we have confirmed, the haematological abnormalities. Nevertheless, a causal role, even a major one, seems probable in many patients, especially in view of the reports of neuropsychiatric improvement with the appropriate vitamin replacement.6 10 One possible reason for some of the differences between the two groups is the younger age of the patients with folate deficiency. The age factor might operate in more than one way.
The younger nervous system might be less vulnerable to the effects of a deficiency, or in the older patients the deficiency might have been present longer, though this last would be difficult to prove. Vitamin B,, deficiency usually takes much longer to develop than folate deficiency owing to the much greater body stores of vitamin B,,. On the other hand, the vulnerability factor may well be important even in vitamin B1, deficiency because the incidence of neuropsychiatric disorders was much higher in the older subgroup with pernicious anaemia.
Although the neuropsychiatric complications of the two deficiencies overlap, one reason for the relatively greater impact of vitamin B,2 deficiency on the peripheral nerves and spinal cord, and of folate deficiency on cerebral function, may be related to the different functional roles of these vitamins in the nervous system. Although little is known of these functions for either vitamin,6 9 it is already apparent that folate and its derivatives have potent excitatory properties and may play a part in synaptic events," whereas there is no evidence for this with vitamin B12. It is interesting, therefore, that deficiency of a substance with excitatory properties leads most commonly to depression. ' The neuropsychiatric features in common between the two deficiencies may possibly be related to their role in nucleoprotein metabolism, although this has been little explored with respect to the nervous system. 
